Cargando…

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma

Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumors of the adrenal medulla and sympathetic/parasympathetic ganglion cells, respectively. Excessive release of catecholamines leads to episodic symptoms and signs of PPGL, which include hypertension, heada...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamilla, Divya, Araque, Katherine A., Brofferio, Alessandra, Gonzales, Melissa K., Sullivan, James N., Nilubol, Naris, Pacak, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678461/
https://www.ncbi.nlm.nih.gov/pubmed/31277296
http://dx.doi.org/10.3390/cancers11070936
_version_ 1783441106433736704
author Mamilla, Divya
Araque, Katherine A.
Brofferio, Alessandra
Gonzales, Melissa K.
Sullivan, James N.
Nilubol, Naris
Pacak, Karel
author_facet Mamilla, Divya
Araque, Katherine A.
Brofferio, Alessandra
Gonzales, Melissa K.
Sullivan, James N.
Nilubol, Naris
Pacak, Karel
author_sort Mamilla, Divya
collection PubMed
description Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumors of the adrenal medulla and sympathetic/parasympathetic ganglion cells, respectively. Excessive release of catecholamines leads to episodic symptoms and signs of PPGL, which include hypertension, headache, palpitations, and diaphoresis. Intraoperatively, large amounts of catecholamines are released into the bloodstream through handling and manipulation of the tumor(s). In contrast, there could also be an abrupt decline in catecholamine levels after tumor resection. Because of such binary manifestations of PPGL, patients may develop perplexing and substantially devastating cardiovascular complications during the perioperative period. These complications include hypertension, hypotension, arrhythmias, myocardial infarction, heart failure, and cerebrovascular accident. Other complications seen in the postoperative period include fever, hypoglycemia, cortisol deficiency, urinary retention, etc. In the interest of safe patient care, such emergencies require precise diagnosis and treatment. Surgeons, anesthesiologists, and intensivists must be aware of the clinical manifestations and complications associated with a sudden increase or decrease in catecholamine levels and should work closely together to be able to provide appropriate management to minimize morbidity and mortality associated with PPGLs.
format Online
Article
Text
id pubmed-6678461
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66784612019-08-19 Postoperative Management in Patients with Pheochromocytoma and Paraganglioma Mamilla, Divya Araque, Katherine A. Brofferio, Alessandra Gonzales, Melissa K. Sullivan, James N. Nilubol, Naris Pacak, Karel Cancers (Basel) Review Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumors of the adrenal medulla and sympathetic/parasympathetic ganglion cells, respectively. Excessive release of catecholamines leads to episodic symptoms and signs of PPGL, which include hypertension, headache, palpitations, and diaphoresis. Intraoperatively, large amounts of catecholamines are released into the bloodstream through handling and manipulation of the tumor(s). In contrast, there could also be an abrupt decline in catecholamine levels after tumor resection. Because of such binary manifestations of PPGL, patients may develop perplexing and substantially devastating cardiovascular complications during the perioperative period. These complications include hypertension, hypotension, arrhythmias, myocardial infarction, heart failure, and cerebrovascular accident. Other complications seen in the postoperative period include fever, hypoglycemia, cortisol deficiency, urinary retention, etc. In the interest of safe patient care, such emergencies require precise diagnosis and treatment. Surgeons, anesthesiologists, and intensivists must be aware of the clinical manifestations and complications associated with a sudden increase or decrease in catecholamine levels and should work closely together to be able to provide appropriate management to minimize morbidity and mortality associated with PPGLs. MDPI 2019-07-03 /pmc/articles/PMC6678461/ /pubmed/31277296 http://dx.doi.org/10.3390/cancers11070936 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mamilla, Divya
Araque, Katherine A.
Brofferio, Alessandra
Gonzales, Melissa K.
Sullivan, James N.
Nilubol, Naris
Pacak, Karel
Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
title Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
title_full Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
title_fullStr Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
title_full_unstemmed Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
title_short Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
title_sort postoperative management in patients with pheochromocytoma and paraganglioma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678461/
https://www.ncbi.nlm.nih.gov/pubmed/31277296
http://dx.doi.org/10.3390/cancers11070936
work_keys_str_mv AT mamilladivya postoperativemanagementinpatientswithpheochromocytomaandparaganglioma
AT araquekatherinea postoperativemanagementinpatientswithpheochromocytomaandparaganglioma
AT brofferioalessandra postoperativemanagementinpatientswithpheochromocytomaandparaganglioma
AT gonzalesmelissak postoperativemanagementinpatientswithpheochromocytomaandparaganglioma
AT sullivanjamesn postoperativemanagementinpatientswithpheochromocytomaandparaganglioma
AT nilubolnaris postoperativemanagementinpatientswithpheochromocytomaandparaganglioma
AT pacakkarel postoperativemanagementinpatientswithpheochromocytomaandparaganglioma